Related Experiment Videos

A 6-year-old boy with fever, rash and severe pneumonia

Kritsana Kongthavonsakul1, Charles Henry Washington, Peninnah Oberdorfer

  • 1Department of Pediatrics, Faculty of Medicine, Chiang Mai, Thailand.

BMJ Case Reports
|May 19, 2012
PubMed

Insights

A 6-year-old unvaccinated boy developed severe measles pneumonia and respiratory distress. Prompt treatment with antibiotics and vitamin A led to recovery, underscoring the importance of vaccination and timely intervention for measles complications.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Measles is a highly contagious viral illness that can lead to serious complications, particularly in unvaccinated children.
  • Pneumonia is a common and potentially severe complication of measles.
  • Vitamin A supplementation is recommended for measles management in certain populations.

Observation:

  • A 6-year-old boy presented with fever, rash, and cough, progressing to severe measles pneumonia and respiratory distress.
  • The patient required admission to the pediatric intensive care unit (PICU) eight days after symptom onset.
  • The child had not received the measles, mumps, and rubella (MMR) vaccination.

Findings:

  • The patient received intravenous antibiotics and high-dose vitamin A.
  • Clinical improvement was observed within three days of treatment.
  • The child was discharged home in stable condition.

Implications:

  • This case emphasizes the critical need for timely diagnosis and appropriate management of measles, including prompt assessment of vaccination status.
  • Early intervention with antibiotics and vitamin A can mitigate severe outcomes like pneumonia in measles patients.
  • Maintaining high vaccination rates for MMR is crucial for preventing measles outbreaks and associated severe illness in children.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...